Ocugen Inc
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
BUGDF Bumrungrad Hospital PCL
ORCL Oracle Corp
OPTT Ocean Power Technologies Inc
SPEYF Spey Resources Corp
BCTX Briacell Therapeutics Corp
JAZZ Jazz Pharmaceuticals PLC
KRT Karat Packaging Inc
REMRF Red Moon Resources Inc
ARR ARMOUR Residential REIT Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Ocugen, Inc., formerly Histogenics Corporation is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of therapies for eye diseases. The Company offers a diversified ophthalmology portfolio that includes gene therapies, biologics, and small molecules and targets a range of retinal and ocular surface diseases. The Company is leveraging its modifier gene therapy platform to address genetically diverse inherited retinal disorders and dry age-related macular degeneration (AMD), based on nuclear hormone receptor genes NR2E3 (OCU400) and RORA (OCU410), respectively. The Company is also developing biologic therapies for wet-AMD, diabetic macular edema (DME) and diabetic retinopathy (OCU200), as well as for retinitis pigmentosa (OCU100).

Price
Delayed
$7.18
Day's Change
-0.225 (-3.04%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.44
Day's Low
7.09
Volume
(Heavy Day)

Today's volume of 7,619,474 shares is on pace to be much greater than OCGN's 10-day average volume of 52,339,969 shares.

7,619,474
  • Prev Close
    7.40
  • Today's Open
    7.32
  • Day's Range
    7.09-7.44
  • Avg Vol (10-day)
    52.3M
  • Last (time)
    9:54a ET 06/22/21
  • Last (size)
    100
  • 52-Wk Range
    0.185 - 18.77
    LowHigh
  • (07/14/20 - 02/08/21)
    3,778.38%
  • 263.4%
  • Market Cap
    1.4B
  • Shares Outstanding
    198.2M
  • -0.33
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 4.5
  • 12.17
  • (% of float 05/28/21)
    23.52

Latest News

June 22, 2021
9:00 am ET
Newsfile
5:40 am ET
Accesswire
June 21, 2021
7:48 pm ET
BusinessWire
6:17 pm ET
Accesswire
5:46 pm ET
Globe Newswire
4:34 pm ET
Newsfile
3:00 pm ET
Accesswire
3:00 pm ET
BusinessWire
12:49 pm ET
Accesswire
12:15 pm ET
BusinessWire
12:00 pm ET
Accesswire
11:30 am ET
Accesswire
11:01 am ET
Accesswire
9:12 am ET
Globe Newswire
5:40 am ET
Accesswire
June 20, 2021
2:18 pm ET
Globe Newswire
1:10 pm ET
BusinessWire
11:35 am ET
Accesswire
11:11 am ET
Accesswire
June 18, 2021
10:00 pm ET
BusinessWire
8:35 pm ET
Accesswire
8:35 pm ET
Accesswire
8:28 pm ET
Globe Newswire
8:03 pm ET
PR Newswire
7:04 pm ET
BusinessWire
5:06 pm ET
BusinessWire
4:42 pm ET
Newsfile
4:12 pm ET
Globe Newswire
2:52 pm ET
Globe Newswire
1:04 pm ET
Newsfile
10:03 am ET
Newsfile
9:57 am ET
Newsfile
June 17, 2021
10:02 am ET
Newsfile
June 16, 2021
6:30 pm ET
BusinessWire
4:30 pm ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.